BioMed Central, BMC Infectious Diseases, 1(15), 2015
DOI: 10.1186/s12879-015-0768-4
Full text: Download
Abstract Background Several in vitro studies suggested the microRNA-29 (miRNA-29) family is involved in regulating HIV-1 and modulating the expression of interleukin (IL)-32, an anti-HIV-1 cytokine. Methods To investigate the contribution of the miRNA-29 family to HIV-1 infection in vivo , we compared miRNA-29 expression in PBMC collected from 58 HIV-1-infected patients, naïve for antiretroviral therapy, and 21 gender- and age-matched HIV-1 seronegative healthy donors, using RT-Taqman assays. The relation between miRNA-29 levels and HIV-1 viro-immunological markers and the activation rate of antiviral immune response were also evaluated. In addition, we profiled miRNA-29 expression in CD4+ T lymphocytes and CD14+ monocytes collected from 5 antiretroviral treated HIV-1 infected patients. Results miRNA-29b levels were higher in HIV-1-infected patients than in the control group (p